Shares of Regenxbio Inc . (NASDAQ: RGNX) surged 18.4% in pre-open trading Tuesday following the announcement of a strategic partnership with Nippon Shinyaku Co., Ltd. for the development and ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

With its lead therapy now in the clinic and new financing in hand, Tune will begin developing other gene and cell therapy programs. “We are well-positioned to advance our HBV clinical program, to ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several measurement techniques commonly used in gene therapy.

It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

Researchers have developed a flexible, biodegradable electrode capable of stimulating neural precursor cells (NPCs) in the ...

One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to ...

For one of Nashville’s public companies, 2024 was a rough year. Cryoport President and CEO Jerrell Shelton attributed most of ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced ...